P. Olbert

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression

Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I

Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase1 1The authors thank Dr. Luitpold E. Miller for his assistance in the preparation of this manuscript; the doctors and nurses of the Endoscopy department; the surgeons and pathologists of the University of Regensburg, especially Dr. Frauke Bataille, for their ongoing great cooperation; and, most importantly, all patients who agreed to give biopsy and tissue samples, without whom this study would not have been possible.

Kidney stones: pathophysiology and medical management

Prevention and Management of Complications Following Radical Cystectomy for Bladder Cancer

Integrins in cancer: biological implications and therapeutic opportunities

Cancer to bone: a fatal attraction

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Liposomal nanomedicines in the treatment of prostate cancer

Therapeutic Efficacy Evaluation of¹¹¹In-Labeled PEGylated Liposomal Vinorelbine in Murine Colon Carcinoma with Multimodalities of Molecular Imaging

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

Review of renal cell carcinoma and its common subtypes in radiology

The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses

Inflammatory bowel disease: cause and immunobiology

Calcification of Multipotent Prostate Tumor Endothelium

Scleroderma

Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury

Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials

The Guy's Stone Score—Grading the Complexity of Percutaneous Nephrolithotomy Procedures

Impact of skeletal complications on patients’ quality of life, mobility, and functional independence

Fibrocytes: emerging effector cells in chronic inflammation

Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference

Classification of Percutaneous Nephrolithotomy Complications Using the Modified Clavien Grading System: Looking for a Standard

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Percutaneous nephrolithotomy: an update

Renal Cell Carcinoma: Dynamic Contrast-enhanced MR Imaging for Differentiation of Tumor Subtypes—Correlation with Pathologic Findings

Transglutaminases: crosslinking enzymes with pleiotropic functions

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Doxil® — The first FDA-approved nano-drug: Lessons learned

Fibrocytes: Bringing new insights into mechanisms of inflammation and fibrosis

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Liposomes as nanomedical devices

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Endogenous microRNA sponges: evidence and controversy

Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice

Renal cell carcinoma

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

Adiponectin as a growth inhibitor in prostate cancer cells

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)

Clinical Pharmacology of Liposomal Anthracyclines: Focus on Pegylated Liposomal Doxorubicin

Mesenchymal Stem Cells as Therapeutics

Systematic review and meta-analysis of enhanced recovery programmes in surgical patients

Fibronectin Stimulates Non–Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal Pathways

A New Concept for Early Recovery after Surgery for Patients Undergoing Radical Cystectomy for Bladder Cancer: Results of a Prospective Randomized Study

Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities

New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?

Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery

Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer

Mechanisms of Renal Fibrosis

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Effect of Factor XIII on Endothelial Barrier Function

Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinoma

CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder

Geschlechtsspezifische Charakteristika und Prognose des Nierenzellkarzinoms

Fast-track-Konzepte im perioperativen Management bei Zystektomie und Harnableitung

Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy

Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer

Metastatic non‐clear cell renal cell carcinoma: current therapeutic options

Plasma Levels of Cellular Fibronectin in Patients with Localized and Metastatic Renal Cell Carcinoma

Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel

Factor XIII in Chronic Inflammatory Bowel Diseases

Pre- and perioperative predictors of short-term clinical outcomes in patients undergoing percutaneous nephrolitholapaxy

875 A prospectively randomized phase II trial of pegylated doxorubicin in hormone refractory prostate cancer

897 High-dose ibandronate is effective and well tolerated in the treatment of pain and hypercalcaemia due to metastatic urologic cancer